MedPath

The Effects of Rye Crisp Bread on Appetite and Metabolic Function

Not Applicable
Completed
Conditions
Appetite Regulation
Interventions
Other: Rye crisp bread B
Other: Rye crisp bread A
Other: Wheat crisp bread C
Registration Number
NCT02011217
Lead Sponsor
Swedish University of Agricultural Sciences
Brief Summary

The aim of this study is to contribute to a better understanding of how dietary fibre in rye affects appetite and metabolic processes. We will evaluate how the intake of rye crisp breads affects appetite, insulin secretion and glucose levels in the blood in healthy humans. We will also investigate microstructural properties of the crisp breads with microscopy, as well as to characterize the food products with respect to the content of dietary fibre and certain bioactive compounds. The aim is also to try to elucidate how observed effects on appetite are related to changes in insulin and glucose levels, appetite related hormonal signals and microstructural properties to verify findings from previous studies.

Detailed Description

The short-term effects (up to 4 hours after intake) of rye crisp breads on subjective appetite and metabolism will be evaluated using a randomized cross-over study design. Each participant will consume three different breakfasts consisting of two different rye crisp breads and one wheat crisp bread on three different occasions separated by a 1 week wash-out period. Participants will rate subjective appetite (satiety, hunger and desire to eat) by using a visual analogue scale (VAS) every 30 min during a 4-hour period, starting 30 min before breakfast. Blood samples will be collected before breakfast and at regular intervals throughout the day for analysis of glucose, insulin and hormone levels. Gastric emptying rate will also be evaluated using paracetamol as an indicator. Glucose and hormonal responses will be related to subjective appetite and to differences in composition of the breakfasts.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
25
Inclusion Criteria
  • Habitual breakfast eaters
Exclusion Criteria
  • Pregnancy, lactation or wishing to become pregnant during the study period
  • Dieting
  • Weightloss
  • Eating disorder
  • Hyperglycemic
  • Hyperinsulinemic
  • Thyroid disease
  • Metabolic issues
  • Diabetes
  • Physical or psychological problems with eating
  • Food intolerance/allergies to foods included in the study
  • Intolerance/allergy to paracetamol
  • Heavy smokers
  • Recent or concurrent participation in a dietary intervention research study

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Rye crisp bread ARye crisp bread B-
Rye crisp bread AWheat crisp bread C-
Rye crisp bread BRye crisp bread A-
Rye crisp bread BWheat crisp bread C-
Wheat crisp bread CRye crisp bread A-
Wheat crisp bread CRye crisp bread B-
Primary Outcome Measures
NameTimeMethod
Subjective Appetite Profiles during 4 hours-30, 0, 30, 60, 90, 120, 150, 180, 210, 240 minutes

Subjective feelings of appetite (satiety, hunger and desire to eat) assessed by visual analogue scale (VAS).

Secondary Outcome Measures
NameTimeMethod
Gastric Emptying Rate during 4 hours-15, 15, 35, 65, 95, 125, 185, 230 minutes

Paracetamol (1 g) taken with breakfast. The appearance of paracetamol in the blood is directly related to the rate of gastric emptying.

Hormonal Responses during 4 hours-15, 15, 35, 65, 95, 125, 185, 230 minutes

Glucagon, glucagon-like peptide-1 (GLP-1), glucose-dependent insulino-tropic polypeptide (GIP), peptide YY (PYY), cholecystokinin (CCK), leptin and ghrelin are measured in plasma samples.

Glucose and Insulin Responses during 4 hours-15, 15, 35, 65, 95, 125, 185, 230 minutes

Glucose and insulin are measured in plasma samples.

Trial Locations

Locations (1)

Paediatric Research Facility; The Children's Hospital at Uppsala University Hospital

🇸🇪

Uppsala, Sweden

© Copyright 2025. All Rights Reserved by MedPath